P01-45 Twenty-four months efficacy and safety of LB03002, a new sustained release formulation of rhGH, in children with GHD: Extension of a phase III randomized multicentre study
Saenger, P, Khadilkar, V, Radjuk, K.A, Bolshova, E, Khadgawat, R, El Kholy, M, Desai, M, Peterkova, V, Mericq, V, Ji, H.-J, Bae, Y.J, Lopez, P, Martin, D
Published in Growth hormone & IGF research (01.10.2012)
Published in Growth hormone & IGF research (01.10.2012)
Get full text
Journal Article
OR14,84 Twelve months safety and efficacy of LB03002, a new prolonged release formulation of rhGH, as compared to daily rhGH therapy in treatment-naïve children with growth failure due to insufficient secretion of endogenous growth hormone (GHD)
Saenger, P.H, Khadilkar, V, Radjuk, K.A, Bolshova, E, Khadgawat, R, El Kholy, M, Peterkova, V, Desai, M, Mericq, V, Savoy, C, Ji, H.-J, Zadik, Z, Kratzsch, J, Bidlingmaier, M
Published in Growth hormone & IGF research (2010)
Published in Growth hormone & IGF research (2010)
Get full text
Journal Article